Miptenalimab Biosimilar - Research Grade

Human

LAG3

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2912

P18627

Blue ice

LAG3 is an inhibitory immune checkpoint receptor on activated T cells and a focus of efforts to relieve T-cell exhaustion in cancer and chronic infection research. This research-grade anti-human LAG3 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of miptenalimab, supplied strictly for research use only. Produced to in vivo standards, the ultra-pure, low-endotoxin preparation is offered in scalable milligram (mg) to gram (g) quantities for heavy-usage, high-throughput laboratories. It supports checkpoint blockade studies, functional T-cell assays, in vitro screening, and in vivo immuno-oncology models, where it serves as a consistent control and active reagent.

Detects human LAG3

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.